- Home
- BFS vs ELVN Comparison
BFS vs ELVN Comparison
Compare BFS & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFS
- ELVN
- Stock Information
- Founded
- BFS 1993
- ELVN 2016
- Country
- BFS United States
- ELVN United States
- Employees
- BFS N/A
- ELVN N/A
- Industry
- BFS Real Estate Investment Trusts
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- BFS Real Estate
- ELVN Health Care
- Exchange
- BFS Nasdaq
- ELVN Nasdaq
- Market Cap
- BFS 830.6M
- ELVN 927.8M
- IPO Year
- BFS 1993
- ELVN 2020
- Fundamental
- Price
- BFS $34.51
- ELVN $21.30
- Analyst Decision
- BFS Strong Buy
- ELVN Strong Buy
- Analyst Count
- BFS 1
- ELVN 5
- Target Price
- BFS $45.50
- ELVN $39.60
- AVG Volume (30 Days)
- BFS 51.9K
- ELVN 594.3K
- Earning Date
- BFS 07-31-2025
- ELVN 08-12-2025
- Dividend Yield
- BFS 6.75%
- ELVN N/A
- EPS Growth
- BFS N/A
- ELVN N/A
- EPS
- BFS 1.47
- ELVN N/A
- Revenue
- BFS $274,011,000.00
- ELVN N/A
- Revenue This Year
- BFS $7.78
- ELVN N/A
- Revenue Next Year
- BFS $6.78
- ELVN N/A
- P/E Ratio
- BFS $23.76
- ELVN N/A
- Revenue Growth
- BFS 5.04
- ELVN N/A
- 52 Week Low
- BFS $31.25
- ELVN $13.30
- 52 Week High
- BFS $42.39
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- BFS 53.40
- ELVN 55.53
- Support Level
- BFS $33.89
- ELVN $18.53
- Resistance Level
- BFS $35.44
- ELVN $24.11
- Average True Range (ATR)
- BFS 0.74
- ELVN 1.96
- MACD
- BFS 0.02
- ELVN 0.15
- Stochastic Oscillator
- BFS 57.27
- ELVN 55.68
About BFS Saul Centers Inc.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.